Charles H. Ballow

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Alan Forrest, David E. Nix, Charles H. Ballow et al. · Antimicrobial Agents and Chemotherapy · 1993 · 1.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Jennifer Thomas, Alan Forrest, Sujata M. Bhavnani et al. · Antimicrobial Agents and Chemotherapy · 1998 · 514 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia☆

Sujata M. Bhavnani, Julie A. Drake, Alan Forrest et al. · Diagnostic Microbiology and Infectious Disease · 2000 · 179 citations

Life Sciences, Infectious Diseases, Microbiology +16

Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada

Ronald N. Jones, Charles H. Ballow, Douglas J. Biedenbach et al. · Diagnostic Microbiology and Infectious Disease · 1998 · 160 citations

Life Sciences, Infectious Diseases, Microbiology +14

Trends in antibiotic utilization and bacterial resistance

Charles H. Ballow, Jerome J. Schentag · Diagnostic Microbiology and Infectious Disease · 1992 · 154 citations

Life Sciences, Microbiology, Pharmacotherapy +14